Skip to main content
. 2023 Feb 13;13(3):1537–1549. doi: 10.21037/qims-22-148

Table 2. Performance of the predictive model on the independent validation dataset.

Evaluation Accuracy (SD) AUC (SD) Sensitivity (SD) Specificity (SD)
HER2 83.3% (4.09%) 72.2% (3.61%) 84.6% (5.44%) 80% (7.34%)
Prognosis 77.8% (4.53%) 75.3% (4.13%) 81.8% (6.88%) 71.4% (6.32%)

SD, standard deviation; AUC, area under curve; CI, confidence interval; HER2, human epidermal growth factor receptor 2.

HHS Vulnerability Disclosure